Can the HIV-1 splicing machinery be targeted for drug discovery?
Zodwa Dlamini, Rodney Hull Research, Innovation & Engagements Portfolio, Mangosuthu University of Technology, Durban, South Africa Abstract: HIV-1 is able to express multiple protein types and isoforms from a single 9 kb mRNA transcript. These proteins are also expressed at particular stages...
Guardado en:
Autores principales: | Dlamini Z, Hull R |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/721b7da5553147468d2c4ab2021b8477 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Exploring the Diverse Functional and Regulatory Consequences of Alternative Splicing in Development and Disease
por: M. Brandon Titus, et al.
Publicado: (2021) -
Case Report: A Synonymous Mutation in NF1 Located at the Non-canonical Splicing Site Leading to Exon 45 Skipping
por: Pengzhen Jin, et al.
Publicado: (2021) -
Evolution of the Early Spliceosomal Complex—From Constitutive to Regulated Splicing
por: Sonia Borao, et al.
Publicado: (2021) -
Dynamic Variations of 3′UTR Length Reprogram the mRNA Regulatory Landscape
por: Estanislao Navarro, et al.
Publicado: (2021) -
Mechanisms of Congenital Myasthenia Caused by Three Mutations in the COLQ Gene
por: Xiaona Luo, et al.
Publicado: (2021)